AnaptysBio, Inc. - ANAB Company Short-Term Debt

Graphic logo of AnaptysBio, Inc. (ANAB)

AnaptysBio, Inc. (ANAB) attracts leading immunologists through its academic environment and stock option system to develop anti-inflammatory antibodies. This chart correlates with a financial model where current revenue is based on grants and licensing fees, with the indicator standing at 0.02. The implementation of robotic systems for 24/7 molecule screening significantly accelerates the discovery of new drug candidates.

ANAB (AnaptysBio Inc) Company Short-Term Debts history from 07/04/2022 to 10/29/2026

AnaptysBio Inc. - analytical breakdowns and key metrics (ANAB)

- price and consensus price forecast:
Price Chart AnaptysBio|ANAB - Fair Value Consensus
- market capitalization data:
Market Value AnaptysBio, Inc.|ANAB - Real Price to Acquire Entire Company
- book capitalization data:
Book Value per Share AnaptysBio|ANAB - Book Capitalization|Market Cap to Net Assets Ratio anaptysbio.com|ANAB - Aggregate Asset Value
- debt and liquidity data:
Total Debt to Capital AnaptysBio, Inc.|ANAB - Ratio of Long-Term Indebtedness to Capital|Short-Term Debt to Equity AnaptysBio, Inc.|ANAB - Company Total Debt|Debt to Book Capitalization Ratio AnaptysBio, Inc.|ANAB - Company Long-Term Liabilities|Company Current Liabilities AnaptysBio
Fundamental company valuation:AnaptysBio - ANAB
Product sample of AnaptysBio, Inc.

This metric aggregates all obligations of AnaptysBio, Inc. (ANAB) due within twelve months. This price action reflects the actual speed of credit line servicing, stripping speculative noise from the analysis. For a biotech company developing anti-IL-36 antibodies, liquidity control is critical when funding costly research. By analyzing the snapshot of short-term debt, an investor can identify pivot points in the debt load, which helps avoid purchasing the asset at its peak.

Competitor analysis

Company Short-Term Debt argenx (ARGX)|BNTX: Company Short-Term Loans and Borrowings|ABVX (Abivax) - Company Short-Term Debt|ADMA Corp (ADMA) - Company Current Liabilities|PTGX (Protagonist Therapeutics) - Company Short-Term Debts|Company Short-Term Debts immunovant.com (IMVT)|Kiniksa (KNSA) - Company Current Liabilities|Company Short-Term Loans and Borrowings Grifols SA (GRFS)|Company Short-Term Debts ADPT|Celldex Corp - Short-Term Debt Volume|AUPH: Company Short-Term Debt|BCRX: Company Current Liabilities|VERA (Vera Therapeutics) - Company Short-Term Debt|Company Current Liabilities Dianthus Therapeutics Inc|PHVS (Pharvaris Corp) - Company Current Liabilities|Company Short-Term Debts ABCL|Company Short-Term Debt Tourmaline Bio, Inc. TRML|Company Short-Term Indebtedness precigen.com (PGEN)|PHAR: Company Short-Term Debts|Short-Term Debt Nektar Therapeutics Inc NKTR|Upstream Bio Corp - Company Short-Term Debts|ZBIO: Company Short-Term Debts|Company Short-Term Debt Immunome, Inc.|gossamerbio.com (GOSS) - Company Short-Term Indebtedness|KALV (KalVista Pharmaceuticals, Inc.) - Company Short-Term Debts|Company Short-Term Debts SEPN|PVLA - Company Short-Term Debt|Current Liabilities Savara Pharma SVRA|Company Current Liabilities Rigel Pharmaceuticals (RIGL)|ATXS - Amount of Current Liabilities|ENGN (enGene) - Company Current Liabilities|RAPT: Short-Term Debt|aerovatetx.com - Company Short-Term Debt|Aclaris Therapeutics, Inc (ACRS) - Short-Term Debt Volume|Company Short-Term Debts Kyverna Therapeutics|Company Short-Term Debt tizianalifesciences.com|CABA (Cabaletta Bio) - Company Short-Term Debts|Short-Term Debt Volume VTYX (Ventyx Biosciences Inc.)|THTX: Company Short-Term Debt|AVTX - Short-Term Debt|Company Current Liabilities Eledon Pharmaceuticals (ELDN)|AGEN - Company Short-Term Loans and Borrowings|Climb Bio - Company Short-Term Debts|ZURA (zurabio.com) - Short-Term Debt Volume|Company Short-Term Debt aTyr (ATYR)|Company Short-Term Indebtedness Adagene Corp|Company Short-Term Debts IMA (ImageneBio Inc)|Company Current Liabilities shattucklabs.com STTK|Company Current Liabilities EQ|Short-Term Debt Volume Connect Biopharma Holdings CNTB|Immunic Inc - Company Short-Term Debts|ATRA: Company Short-Term Debts|Company Short-Term Debt inflarx.de|x4pharma.com (XFOR) - Company Short-Term Indebtedness|ACET (Adicet Bio Inc.) - Company Short-Term Debts|Company Short-Term Debts Celularity Corp|Company Short-Term Debts INmune Bio Corp (INMB)|Company Short-Term Debt BRNS (Barinthus Biotherapeutics Corp)|Kezar Life Sciences (KZR) - Company Short-Term Debt|Current Liabilities sabbiotherapeutics.com SABS|Company Short-Term Debts Akari Therapeutics Plc (AKTX)|ENLV - Company Short-Term Loans and Borrowings|QTTB: Company Short-Term Debts|GOVX (GeoVax Corp) - Company Short-Term Debts|EDSA - Company Short-Term Debt|Company Short-Term Loans and Borrowings IBIO|Company Short-Term Debt CARM (Carisma Therapeutics)|Company Current Liabilities XTL Biopharmaceuticals Ltd (XTLB)|Company Short-Term Debts BOLT (Bolt Biotherapeutics, Inc.)|HCWB - Company Short-Term Debts|Company Current Liabilities Aptevo (APVO)|AIM - Company Short-Term Loans and Borrowings|aditxt.com - Company Short-Term Debts|GRI (GRI Bio Inc) - Short-Term Debt Volume|Company Short-Term Debt XRTX|Company Current Liabilities HIND|Company Short-Term Debt REVB (Revelation Biosciences)|Company Current Liabilities indaptusrx.com INDP|Company Current Liabilities SCNI (Scinai Immunotherapeutics Ltd.)|CalciMedica Inc - Company Short-Term Debts|Affimed Therapeutics (AFMD) - Company Short-Term Debt|ALLK - Company Short-Term Indebtedness|Company Short-Term Debts HOOK|IGM Biosciences (IGMS) - Short-Term Debt|ITOS (iTeos Therapeutics, Inc.) - Company Short-Term Debts|Company Short-Term Debts OCEA|Company Short-Term Debt TC BioPharm (Holdings) PLC TCBP|Company Short-Term Indebtedness Third Harmonic Bio Inc (THRD)